AU2002240094A1 - Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof - Google Patents

Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof

Info

Publication number
AU2002240094A1
AU2002240094A1 AU2002240094A AU2002240094A AU2002240094A1 AU 2002240094 A1 AU2002240094 A1 AU 2002240094A1 AU 2002240094 A AU2002240094 A AU 2002240094A AU 2002240094 A AU2002240094 A AU 2002240094A AU 2002240094 A1 AU2002240094 A1 AU 2002240094A1
Authority
AU
Australia
Prior art keywords
apoptopic
scc
diagnostic
gene
therapeutic uses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002240094A
Inventor
Imran Ahmad
Prafulla Gokhale
Usha N. Kasid
Deepak Kumar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neopharm Inc
Original Assignee
Neopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharm Inc filed Critical Neopharm Inc
Publication of AU2002240094A1 publication Critical patent/AU2002240094A1/en
Abandoned legal-status Critical Current

Links

AU2002240094A 2001-01-26 2002-01-28 Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof Abandoned AU2002240094A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/264,062 2001-01-26

Publications (1)

Publication Number Publication Date
AU2002240094A1 true AU2002240094A1 (en) 2002-08-06

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002327185A1 (en) Diagnostic methods and devices
EP1247815A3 (en) Modified oligonucleotides and uses thereof
AU2002225219A1 (en) Diagnosis and treatment of multiple sclerosis
AU2002952993A0 (en) Therapeutic and diagnostic agents
AU2002258728A1 (en) Gene brcc-3 and diagnostic and therapeutic uses thereof
AU2002303261A1 (en) Gene brcc2 and diagnostic and therapeutic uses thereof
AU2002305151A1 (en) Gene scc-112 and diagnostic and therapeutic uses thereof
AU2002252976A1 (en) Hydrazones and their therapeutic use
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU2002354070A1 (en) Medical polymers and use thereof
AU2002323286A1 (en) Human toxicologically relevant genes and arrays
AU2002335667A1 (en) Modified reoviral therapy
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2002303262A1 (en) Gene shinc-1 and diagnostic and therapeutic uses thereof
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2002240094A1 (en) Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof
AU2002240921A1 (en) Medane genes and proteins
AUPR556601A0 (en) Therapeutic and diagnostic molecules - II
AU2003235665A1 (en) Diagnostic and therapeutic uses of topors
AU2002953516A0 (en) Genetic therapy and genetic modification
AU2002321141A1 (en) Pyrimidinoxyalkylpiperazines and their therapeutic use
AU2002307532A1 (en) Cobra gene and uses thereof
AUPR491901A0 (en) Cancer diagnosis and therapy
AUPR713201A0 (en) Novel therapeutic molecules and uses therefor
AU2002328502A1 (en) Novel human bmcc1 gene